-
OncoC4 and AcroImmune Announce Merger | Morningstar
来源: Buzz FX / 25 9月 2024 06:57:20 America/Chicago
[GlobeNewswire](/news/globe-newswire) OncoC4 and AcroImmune Announce Merger Merger expands OncoC4’s wholly owned immunotherapy pipeline and establishes in-house clinical manufacturing capabilities Adds IND-ready AI-081, a PD-1/VEGF bispecif
Read more...